Akira Okuno
The University of Tokyo · 24 works · 3,308 citations · h-index 13
Top works
- PPARγ Mediates High-Fat Diet–Induced Adipocyte Hypertrophy and Insulin Resistance
- Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats.
- Increased insulin sensitivity and hypoglycaemia in mice lacking the p85α subunit of phosphoinositide 3–kinase
- Antihypertensive effects of CS-045 treatment in obese Zucker rats
- Suppression of hepatic gluconeogenesis in long-term troglitazone treated diabetic KK and mice
- Acute Hyperglycemia Provides an Insulin-Independent Inducer for GLUT4 Translocation in C2C12 Myotubes and Rat Skeletal Muscle
- Troglitazone, a new antidiabetic agent possessing radical scavenging ability, improved decreased skin blood flow in diabetic rats
- Identification of Molecular Target of AMP-activated Protein Kinase Activator by Affinity Purification and Mass Spectrometry
- Acute effect of troglitazone on glucose metabolism in the absence or presence of insulin in perfused rat hindlimb
- Dynamic Changes of Adiponectin and S100A8 Levels by the Selective Peroxisome Proliferator–Activated Receptor-γ Agonist Rivoglitazone
- Metformin primarily decreases plasma glucose not by gluconeogenesis suppression but by activating glucose utilization in a non-obese type 2 diabetes Goto-Kakizaki rats
- CS-917, a fructose 1,6-bisphosphatase inhibitor, improves postprandial hyperglycemia after meal loading in non-obese type 2 diabetic Goto-Kakizaki rats
- Plasma Profiles of Glucose, Insulin and Lipids in the Male WBN/Kob-Leprfa Rat, a New Model of Type 2 Diabetes with Obesity
- Role of Insulin Resistance in the Pathogenesis and Development of Type 2 Diabetes in WBN/Kob-Leprfa Rats
- Discovery of potent and orally active tricyclic-based FBPase inhibitors
- A prodrug approach towards the development of tricyclic-based FBPase inhibitors
- Contributions of Hepatic Gluconeogenesis Suppression and Compensative Glycogenolysis on the Glucose-Lowering Effect of CS-917, a Fructose 1,6-Bisphosphatase Inhibitor, in Non-obese Type 2 Diabetes Goto-Kakizaki Rats
- Absorption, Elimination, and Metabolism of CS-1036, a Novel α-Amylase Inhibitor in Rats and Monkeys, and the Relationship between Gastrointestinal Distribution and Suppression of Glucose Absorption
- Thermally Driven Vehicle Using Bimetal Rings
- Study on the Improvement Effect of Troglitazone, an Antidiabetic Agent, on Insulin Resistance